The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

H.C. Wainwright analyst Joseph Pantginis has reiterated their bullish stance on VKTX stock, giving a Buy rating on January 9.Stay Ahead of the ...

Ozempic was quickly deemed a “miracle” medication, though few could predict how quickly and vastly it would revolutionise the weight loss industry ... trials for oral semaglutide in weight ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria B ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...